Hearing News Watch

A 2025 study published in the Journal of Translational Medicine reports a nanoparticle system that could keep medications in the ear longer and improve how much drug reaches the cochlea—potentially reducing the need for repeated injections to treat certain types of hearing loss. The approach uses polydopamine-coated, mucoadhesive nanoparticles (“Dopa-NPs”) to help medicine stick to ear tissues and cross into

LEXINGTON, KENTUCKY – The Academy of Doctors of Audiology (ADA) has announced that registration is now open for the inaugural cohort of the ADA Audiology Practice Accreditation Program. The registration deadline is Friday, December 5, 2025, or until a maximum of 50 practices have registered. The ADA Audiology Practice Accreditation initiative aims to help practices strengthen and streamline operations, align with

CHICAGO, ILLINOIS – Beltone has launched its third annual Hear for the Holidays campaign, an initiative designed to help individuals with hearing loss reconnect with loved ones during the holiday season. Through December 31, people can nominate themselves or someone they know to receive a free pair of hearing aids from participating Beltone hearing centers across the United States. Recipients

CAMBRIDGE, UNITED KINGDOM – CamGene Therapeutics, a biotechnology company developing first-in-class RNA-based therapies for hearing loss, has announced the successful closing of its oversubscribed seed funding round. The financing was led by the UK Innovation & Science Seed Fund (UKI2S), managed by Future Planet Capital, and joined by majority investor Eos Advisory, as well as Cambridge Enterprise Ventures, Hex Two, LongRiver

MILAN, ITALY – Amplifon S.p.A. announced its results for the first nine months and third quarter ended September 30, 2025. The company reported revenues of €1,743.8 million (~$1.87 billion) for the first nine months, an increase of 1.8% at constant exchange rates compared to the same period in 2024. The improvement was driven by a return to organic growth in

by Terry Mactaggart, President and CEO, Summus Hearing Inc.  My last post (Introducing Merlin – Making Hearing Care Accessible to All) summarized our view of the hearing health conundrum and what we at Summus Hearing (in concert with others) can do about it. While testing abounds online and via hearing aid dispenser/ENT networks, a significant majority of people don’t take

EDEN PRAIRIE, MINNESOTA — Starkey has been named to Fast Company’s 2025 Next Big Things in Tech list, which recognizes innovations reshaping industries and advancing technology with meaningful impact. The distinction highlights Starkey’s role in developing hearing aids that function as intelligent health devices supporting communication, safety, and overall well-being. The Next Big Things in Tech list honors companies of all

SMØRUM, DENMARK — Demant has signed an agreement to sell Oticon Medical to Nordic investment firm Impilo for a total contractual consideration of up to DKK 600 million (approximately USD $85 million). The transaction concludes Demant’s divestment of its Hearing Implants business area. The agreement ensures continuity for Oticon Medical’s operations and supports its long-term market position, future growth, and

ROCKFORD, ILLINIOS — HearAdvisor, an independent audio performance lab, has announced the winners of its 2025 Expert Choice Awards, recognizing the best hearing aids and earplugs of the year. Now in its third year, the awards highlight products that deliver exceptional sound quality and performance based on rigorous, objective lab testing. HearAdvisor remains the only lab worldwide offering independent, data-driven

DUBLIN, IRELAND — Neuromod, the medical device company behind the Lenire tinnitus treatment device, has announced the launch of Tinnitus Masterclass, an online course designed to provide hearing care professionals with clinical and commercial knowledge to establish effective and sustainable tinnitus care services. Tinnitus Masterclass is an expert-led online program that integrates audiology, neurology, and psychology into short, focused modules. The